This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Colicin E8
From Proteopedia
(→Synthesis and release) |
|||
| Line 2: | Line 2: | ||
==Synthesis and release== | ==Synthesis and release== | ||
| + | |||
| + | The ColE8 operon is encoded on a plasmid in the ''E. coli'' cell, and includes the gene encoding [[Im8]], its [[Colicin Immunity Protein]]. When the colicin has been synthesised, the immunity protein binds to the cytotoxic domain, to protect the colicinogenic cell from the killing activity. | ||
==Mechanism of uptake== | ==Mechanism of uptake== | ||
==Killing Activities== | ==Killing Activities== | ||
Revision as of 15:00, 26 February 2011
Colicin E3 is a type of Colicin, a bacteriocin made by E. coli which acts against other nearby E. coli to kill them with its DNase Activity; it digests the host's genome at specific locations, ultimately leading to the death of the cell.
Synthesis and release
The ColE8 operon is encoded on a plasmid in the E. coli cell, and includes the gene encoding Im8, its Colicin Immunity Protein. When the colicin has been synthesised, the immunity protein binds to the cytotoxic domain, to protect the colicinogenic cell from the killing activity.
